Type 2 diabetes is one of the fastest growing preventable health conditions in Aotearoa New Zealand. It can cause serious complications including heart attacks and strokes, kidney disease, blindness and limb amputations. EDOR researchers are working on ways to prevent and better manage this chronic disease.
In 2021 EDOR contributed to a report into the scale and cost of type 2 diabetes. The report found that nearly 5% of New Zealanders have type 2 diabetes and this is forecast to increase by 70-90% over the next twenty years. The current annual cost of type 2 diabetes in New Zealand is $2.1 billion, which is 0.67% of our country's GDP.
There are significant ethnic inequalities among those affected by this disease, with rates being much higher in Māori, Pacific, Asian and Indian communities.
Read more about the cost of type 2 diabetes report
Recent research projects
- The 2GO-CGM study: glycaemic outcomes in people with type 2 diabetes initiating CGM
- Fibre and diabetes management
- Healthy food for your heart trial
- Hunger Training to prevent diabetes
- Whole Grains for Health study
- Wholegrain processing: acute
- Wholegrain processing: medium term
Previous research
- LOADD: Lifestyle Over and Above Drugs in Diabetes
- Ngati and Healthy: Prevent Diabetes Project
- Optimal diet composition for the prevention of diabetes
- Otago Diabetes Project
- Quality of diabetes foot care in Oman
- Family based Pacific child obesity prevention
- Validation of a new clinical test for insulin sensitivity
- Porirua Union case study
- Pacific intervention: Diabetes, obesity and the church
- The prevalence of diabetes and prediabetes in New Zealand
In the news
Extensive type 2 diabetes screening in NZ has led to better cardiovascular risk prediction
EDOR directors instrumental in Type 2 Diabetes report
Better podiatry services would avoid 600 diabetes-related amputations per year
Action needed on Type 2 Diabetes
Cost of Type 2 Diabetes report launched at Parliament
